---
figid: PMC8468947__pharmaceuticals-14-00868-g003
figtitle: 'Lactoferrin and Its Potential Impact for the Relief of Pain: A Preclinical
  Approach'
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Camelus dromedarius
- Homo sapiens
- Escherichia coli LF82
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8468947
filename: pharmaceuticals-14-00868-g003.jpg
figlink: /pmc/articles/PMC8468947/figure/pharmaceuticals-14-00868-f003/
number: F3
caption: Anti-nociceptive potentiation of bovine lactoferrin (bLf) and opioids. Ligands
  of opioid receptors activate the phosphoinositide 3-kinase (PI3K)–AKT signaling
  pathway, favoring the production of nitric oxide (NO). The generation of NO culminates
  in the activation of the NO–cyclic guanine monophosphate (cGMP) signaling pathway
  that, together with opioid receptor-mediated protein G-activation, opens the ATP-sensitive
  K+ channels. It is probable that bLf potentiates the effects of opioids because
  it can act on opioid receptors and/or induce the activation of the PI3K–AKT signaling
  pathway. This figure was created with Biorender.com.
papertitle: 'Lactoferrin and Its Potential Impact for the Relief of Pain: A Preclinical
  Approach.'
reftext: Beatriz Godínez-Chaparro, et al. Pharmaceuticals (Basel). 2021 Sep;14(9):868.
year: '2021'
doi: 10.3390/ph14090868
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: lactoferrin | pain | opioids | NO | NFκB
automl_pathway: 0.9566556
figid_alias: PMC8468947__F3
figtype: Figure
redirect_from: /figures/PMC8468947__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8468947__pharmaceuticals-14-00868-g003.html
  '@type': Dataset
  description: Anti-nociceptive potentiation of bovine lactoferrin (bLf) and opioids.
    Ligands of opioid receptors activate the phosphoinositide 3-kinase (PI3K)–AKT
    signaling pathway, favoring the production of nitric oxide (NO). The generation
    of NO culminates in the activation of the NO–cyclic guanine monophosphate (cGMP)
    signaling pathway that, together with opioid receptor-mediated protein G-activation,
    opens the ATP-sensitive K+ channels. It is probable that bLf potentiates the effects
    of opioids because it can act on opioid receptors and/or induce the activation
    of the PI3K–AKT signaling pathway. This figure was created with Biorender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTG1
  - ATP8A2
  - NOS1
  - PRKG1
  - Lrp1
  - Mvp
  - Txlng
  - Pik3r1
  - Akt1
  - Nos1
  - arr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - ATPsynbeta
  - Atpalpha
  - Nos
  - nos
  - Pkg21D
  - for
---
